Assessment of neutrophil-lymphocyte ratio in ulcerative colitis: A promising marker in predicting disease severity

Clinics and Research in Hepatology and Gastroenterology

Volumn 36, Issue 5, 2012, Pages 491-497

  Torun, Serkan ^a   Tunc, Bilge Demirel ^a   Suvak, Burak ^a   Yildiz, Hakan ^a   Tas, Adnan ^b   Sayilir, Abdurrahim ^a   Ozderin, Yasemin Ozin ^a   Beyazit, Yavuz ^a   Kayacetin, Ertugrul ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b Osmaniye Public Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LEUKOCYTE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; NEUTROPHIL LYMPHOCYTE RATIO; PREDICTIVE VALUE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; ULCERATIVE COLITIS;

ADULT; BIOLOGICAL MARKERS; COLITIS, ULCERATIVE; FEMALE; HUMANS; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPHILS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84868380890     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2012.06.004     Document Type: Article

References (36)

1. Tibble J.A., Bjarnason I. Non-invasive investigation of inflammatory bowel disease. World J Gastroenterol 2001, 7:460-465.
2. Cakal B., Akoz A.G., Ustundag Y., Yalinkilic M., Ulker A., Ankarali H. Red cell distribution width for assessment of activity of inflammatory bowel disease. Dig Dis Sci 2009, 54:842-847.
3. Mack D.R., Langton C., Markowitz J., et al. Laboratory values for children with newly diagnosed inflammatory bowel disease. Pediatrics 2007, 119:1113-1119.
4. Xiang J.Y., Ouyang Q., Li G.D., Xiao N.P. Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis. World J Gastroenterol 2008, 14:53-57.
5. Yüksel O., Helvaci K., Başar O., Köklü S., Caner S., Helvaci N., et al. An overlooked indicator of disease activity in ulcerative colitis: mean platelet volume. Platelets 2009, 20:277-281.
6. Halazun K.J., Aldoori A., Malik H.Z., Al-Mukhtar A., Prasad K.R., Toogood G.J., et al. Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol 2008, 34:55-60.
7. Kishi Y., Kopetz S., Chun Y.S., Palavecino M., Abdalla E.K., Vauthey J.N. Blood neutrophil to lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. Ann Surg Oncol 2009, 16:614-622.
8. Yamanaka T., Matsumoto S., Teramukai S., Ishiwata R., Nagai Y., Fukushima M. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology 2007, 73:215-220.
9. Cho H., Hur H.W., Kim S.W., Kim S.H., Kim J.H., Kim Y.T., et al. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother 2009, 58:15-23.
10. Gomez D., Morris-Stiff G., Toogood G.J., Lodge J.P., Prasad K.R. Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma. J Surg Oncol 2008, 97:513-518.
11. Gomez D., Farid S., Malik H.Z., Young A.L., Toogood G.J., Lodge J.P., et al. Preoperative neutrophil to lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World J Surg 2008, 32:1757-1762.
12. Halazun K.J., Hardy M.A., Rana A.A., Woodland D.C., Luyten E.J., Mahadev S., et al. Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma. Ann Surg 2009, 250:141-151.
13. An X., Ding P.R., Li Y.H., Wang F.H., Shi Y.X., Wang Z.Q., et al. Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer. Biomarkers 2010, 15:516-522.
14. Zahorec R. Ratio of neutrophil to lymphocyte counts - rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 2001, 102:5-14.
15. Goodman D.A., Goodman C.B., Monk J.S. Use of the neutrophil:lymphocyte ratio in the diagnosis of appendicitis. Am Surg 1995, 61:257-259.
16. Tamhane U.U., Aneja S., Montgomery D., Rogers E.K., Eagle K.A., Gurm H.S. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol 2008, 102:653-657.
17. Bhutta H., Agha R., Wong J., Tang T.Y., Wilson Y.G., Walsh S.R. Neutrophil-lymphocyte ratio predicts medium-term survival following elective major vascular surgery: a cross-sectional study. Vasc Endovascular Surg 2011, 45:227-231.
18. Azab B., Jaglall N., Atallah J.P., Lamet A., Raja-Surya V., Farah B., et al. Neutrophil-lymphocyte ratio as a predictor of adverse outcomes of acute pancreatitis. Pancreatology 2011, 11:445-452.
19. Truelove S.C., Witts L.J. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 1955, 2:1041-1048.
20. Stange E.F., Travis S.P., Vermeire S., Reinisch W., Geboes K., Barakauskiene A., et al. European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohn Colitis 2008, 2:1-23.
21. Cima R.R., Pemberton J.H. Medical and surgical management of chronic ulcerative colitis. Arch Surg 2005, 140:300-310.
22. Beyazit Y., Koklu S., Tas A., Purnak T., Sayilir A., Kurt M., et al. Serum adenosine deaminase activity as a predictor of disease severity in ulcerative colitis. J Crohns Colitis 2012, 6:102-107.
23. Travis S.P. Review article: the management of mild to severe acute ulcerative colitis. Aliment Pharmacol Ther 2004, 20(Suppl. 4):88-92.
24. Naber A.H., de Jong D.J. Assessment of disease activity in inflammatory bowel disease; relevance for clinical trials. Neth J Med 2003, 61:105-110.
25. Bruining D.H., Loftus E.V. Current and future diagnostic approaches: from serologies to imaging. Curr Gastroenterol Rep 2007, 9:489-496.
26. Karoui S., Laz S., Serghini M., Bibani N., Boubaker J., Filali A. Correlation of C-reactive protein with clinical and endoscopic activity in patients with ulcerative colitis. Dig Dis Sci 2011, 56:1801-1805.
27. Khan K., Schwarzenberg S.J., Sharp H., Greenwood D., Weisdorf-Schindele S. Role of serology and routine laboratory tests in childhood inflammatory bowel disease. Inflamm Bowel Dis 2002, 8:325-329.
28. Prantera C., Davoli M., Lorenzetti R., Pallone F., Marcheggiano A., Iannoni C., et al. Clinical and laboratory indicators of extent of ulcerative colitis. Serum C-reactive protein helps the most. J Clin Gastroenterol 1988, 10:41-45.
29. Zezos P., Papaioannou G., Nikolaidis N., Patsiaoura K., Vassiliadis T., Mpoumponaris A., et al. Elevated markers of thrombin generation and fibrinolysis in patients with active and quiescent ulcerative colitis. Med Sci Monit 2009, 15:CR563-CR572.
30. Duffy B.K., Gurm H.S., Rajagopal V., Gupta R., Ellis S.G., Bhatt D.L. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long term mortality after percutaneous coronary intervention. Am J Cardiol 2006, 97:993-996.
31. Azab B., Zaher M., Weiserbs K.F., Torbey E., Lacossiere K., Gaddam S., et al. Usefulness of neutrophil to lymphocyte ratio in predicting short and long term mortality after non-ST-elevation myocardial infarction. Am J Cardiol 2010, 106:470-476.
32. Nixon J., Riddell R Histopathology in ulcerative colitis. Inflammatory bowel disease 1990, 247-285. Churchill Livingstone, Edinburgh. R. Allan, M. Keighley, C. Alexander-Williams, C. Hawkins (Eds.).
33. Hermanowicz A., Gibson P.R., Jewell D.P. The role of phagocytes in inflammatory bowel disease. Clin Sci (Lond) 1985, 69:241-249.
34. Brannigan A.E., O'Connell P.R., Hurley H., O'Neill A., Brady H.R., Fitzpatrick J.M., et al. Neutrophil apoptosis is delayed in patients with inflammatory bowel disease. Shock 2000, 13:361-366.
35. Roche J.K., Watkins M.H., Cook S.L. Inflammatory bowel disease: prevalence and level of activation of circulating T-lymphocyte subpopulations mediating suppressor/cytotoxic and helper function as defined by monoclonal antibodies. Clin Immunol Immunopathol 1982, 25:362-373.
36. Sachar D.B., Taub R.N., Brown S.M., Present D.H., Korelitz B.I., Janowitz H.D. Imparied lymphocyte responsiveness in inflammatory bowel disease. Gastroenterology 1973, 64:203-209.